In this edition
– Characteristics, management and outcomes in congestive HF
– Dapagliflozin and mode of death in HF with improved EF
– Changes in walking speed and handgrip strength after HF hospitalisation
– Vericiguat vs. sacubitril-valsartan for HFREF
– Sex disparities in guideline-directed medical therapy for HF
– Association of β-blocker use with exercise capacity in HFPEF
– Sacubitril-valsartan in hospitalised decompensated HF
– BP, hypertension and HF risk
– Prevalence of subclinical AF in HFPEF
– Treatment effect of intravenous iron in iron-deficient HF
Download the Heart Failure Research Review Issue 85, with commentary by Prof Andrew Coats

